Understanding Patient Access Programs

Watch our recent webinar "Understanding Patient Access Programs", hosted by LSX. Hear from MCRA industry experts, Daria Schuman, Senior Director of Reimbursement, Health Economics & Market Access and Aleshia Polk, Senior Director of Patient Access Program Operations. Daria and Aleshia discuss patient access programs and their strategic utility during pre- and post-market clinical trials. Though not a "one-size-fits-all" approach, utilizing Patient Access solutions during the clinical trial phase serves as the foundation for executing on a longer-term reimbursement strategy.

MCRA's reimbursement team works with many early-stage companies to define and execute successful US reimbursement and market access strategies across all medical devices. MCRA's full service CRO can fully manage clinical studies, beginning with study design and protocol development, or provide support to companies as they take lead in study execution. Learn more about our reimbursement and patient access teams here.